These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 7313627)
1. [Fibrinogen Bern I and fibrinogen Bern II: 2 hereditary fibrinogen variants with diverse biochemical properties]. Rupp C; Kuyas C; Haeberli A; Furlan M; von Fliedner V; Beck EA Schweiz Med Wochenschr; 1981 Oct; 111(41):1543-5. PubMed ID: 7313627 [TBL] [Abstract][Full Text] [Related]
2. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain. Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274 [TBL] [Abstract][Full Text] [Related]
3. [Fibrinogen Bern II: hereditary fibrinogen variant with amino acid substitution of arginine replaced by histidine in position 16 of the A alpha chain]. Rupp C; Sievi R; Furlan M; Beck EA Schweiz Med Wochenschr; 1983 Oct; 113(40):1460-2. PubMed ID: 6648427 [TBL] [Abstract][Full Text] [Related]
4. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys]. Furlan M; Leupin L; Biasiutti FD; Lämmle B Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701 [TBL] [Abstract][Full Text] [Related]
5. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain. Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658 [TBL] [Abstract][Full Text] [Related]
6. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis. Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005 [TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Bastia (gamma 318 Asp-->Tyr) a novel abnormal fibrinogen characterized by defective fibrin polymerization. Lounes KC; Soria C; Valognes A; Turchini MF; Soria J; Koopman J Thromb Haemost; 1999 Dec; 82(6):1639-43. PubMed ID: 10613648 [TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Haifa: fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains. Soria J; Soria C; Samama M; Tabori S; Kehl M; Henschen A; Nieuwenhuizen W; Rimon A; Tatarski I Thromb Haemost; 1987 Jun; 57(3):310-3. PubMed ID: 2958955 [TBL] [Abstract][Full Text] [Related]
9. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules. Matsuda M; Baba M; Morimoto K; Nakamikawa C J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002 [TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization. Steinmann C; Reber P; Jungo M; Lämmle B; Heinemann G; Wermuth B; Furlan M Blood; 1993 Oct; 82(7):2104-8. PubMed ID: 8400260 [TBL] [Abstract][Full Text] [Related]
11. [Resolution of Bbeta and gamma chains from normal human fibrinogen Zürich II into 2 variants with each differing sialic acid content]. Gati WP; Straub PW Schweiz Med Wochenschr; 1976 Oct; 106(40):1379. PubMed ID: 1006261 [TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Matsumoto III: a variant with gamma275 Arg-->Cys (CGC-->TGC)--comparison of fibrin polymerization properties with those of Matsumoto I (gamma364 Asp-->His) and Matsumoto II (gamma308 Asn-->Lys). Terasawa F; Okumura N; Higuchi Y; Ishikawa S; Tozuka M; Ishida F; Kitano K; Katsuyama T Thromb Haemost; 1999 May; 81(5):763-6. PubMed ID: 10365751 [TBL] [Abstract][Full Text] [Related]
13. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization. Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826 [TBL] [Abstract][Full Text] [Related]
15. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule. Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865 [TBL] [Abstract][Full Text] [Related]
16. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN. Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657 [TBL] [Abstract][Full Text] [Related]
17. Increase of the sialic acid-rich variants of the B beta- and gamma-chains of fibrinogen Zurich II. Straub PW; Gati WP Thromb Haemost; 1979 Jun; 41(4):714-7. PubMed ID: 483245 [No Abstract] [Full Text] [Related]
18. [Comparison of coagulation screening test results in two cases having dysfibrinogen]. Terasawa F; Sasaki Y; Ishikawa S; Nakagoshi R; Furihata K; Katsuyama T; Okumura N Rinsho Byori; 1996 Aug; 44(8):791-6. PubMed ID: 8816067 [TBL] [Abstract][Full Text] [Related]
19. Cloning of the complete coding sequence of rat fibrinogen B beta chain cDNA: interspecies conservation of fibrin beta 15-42 primary structure. Courtney MA; Bunce LA; Neroni LA; Simpson-Haidaris PJ Blood Coagul Fibrinolysis; 1994 Aug; 5(4):487-96. PubMed ID: 7841303 [TBL] [Abstract][Full Text] [Related]
20. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization. Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]